Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Queensland Health
Boehringer Ingelheim
Deloitte
Accenture
Mallinckrodt
Julphar
Citi
Daiichi Sankyo

Generated: April 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nilotinib hydrochloride monohydrate

« Back to Dashboard

nilotinib hydrochloride monohydrate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0526-87
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0526-51
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0592-87
Novartis TASIGNA nilotinib hydrochloride monohydrate CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation N 0078-0592-51
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
McKesson
Moodys
Mallinckrodt
Federal Trade Commission
Johnson and Johnson
Fuji
Colorcon